RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, will be presenting at the Rodman & Renshaw Global Investment Conference. The Conference will take place September 13-15, 2010 at the New York Palace Hotel in New York, NY.
